“OneOncology was started by physicians and for physicians,” said Jeff Patton, MD, OneOncology CEO. “As we’ve grown and enhanced world-class cancer care in communities across the country, strengthening practice independence and empowering their decision-making has always been our north star."
This press release was originally published by OneOncology.
OneOncology, the fastest growing national platform for independent oncology practices, and its practice partners, celebrate 5 years since creating the OneOncology partnership, which has strengthened independent community oncology through practice growth and expansion, adding high-value services along the continuum of cancer care, and increasing patient access to advanced therapies and cutting-edge clinical trials close to home.
Growth
Over the past 5 years, with capital, best-in-class technology, and deep expertise across the specialty, OneOncology has grown from:
“OneOncology was started by physicians and for physicians,” said Jeff Patton, MD, OneOncology CEO. “As we’ve grown and enhanced world-class cancer care in communities across the country, strengthening practice independence and empowering their decision-making has always been our north star. Partnering with physicians and practices allows us to collaboratively enhance strong cancer programs and fulfill our mission to improve the lives of everyone living with cancer.”
Expanding High-Value Cancer Care Services
Across the OneOncology network during the last 5 years, practices have expanded their quality cancer care services to include lab, pharmacy, radiation, surgery, imaging, nuclear medicine, nurse navigators, palliative care, nutrition, physical therapy, patient financial services, social services, and genetic counseling. Nearly 90 percent of practice partners have in-house lab services and all offer, or will soon offer, in-house pharmacy services to patients. Also, half of OneOncology practice partners have in-house radiation therapy services.
“OneOncology’s practice optimization teams bring our practice partners subject matter expertise allowing them to efficiently offer patients additional high-value services across the continuum of care,” said Todd Stevens, OneOncology’s Chief Operating Officer. “Working hand-in-glove with practice partners is our recipe for success. We bring our partners avenues to reach goals that otherwise would be extremely difficult to achieve on their own.”
Clinical Innovation
OneOncology’s clinical team puts precision medicine services, clinical trials, clinical decision support tools, and learning opportunities in the hands of its physician partners. Since OneOncology was founded, OneOncology has:
“The clinical team puts solutions within physicians’ workflow to support their decision making,” said Davey Daniel, MD, OneOncology’s Chief Medical Officer. “In a short time, we’ve scaled our clinical support tools to offer sub-specialty expertise and pathways, precision medicine services to help our partners navigate the flood of vital clinical and real-world data available to diagnose and treat complex diseases, and learning opportunities to stay up to speed on clinical innovation. Our successes are due to our shared commitment with our physician partners to continually bring the highest-quality care to our patients. We do this by providing cutting-edge clinical trials and testing to patients close to their homes, a key component of ensuring equitable care.”
“OneOncology has accomplished a lot for its practice partners in 5 years,” Dr. Patton said. “I’m humbled by the trust my partners and teams have put in me and am inspired about the opportunity to continue to empower doctors to care for their patients.”
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Understanding Primary and Secondary Nonadherence to Chronic Oral Medication
March 28th 2025Medication nonadherence to oral anticoagulants and oral anti–prostate cancer medication has been scrutinized through new research conducted among patients and health care providers and presented by the American Medical Group Association at its 2025 annual meeting, held March 26-29 in Grapevine, Texas.
Read More
Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot
March 18th 2025Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Read More